According to the news, thousands of people are queuing up for the implantation of "brain computer chips" in Musk Neuralink, and the number of surgeries will exceed 22000 by 2030

On Tuesday local time in the United States, biographer Ashlee Vance revealed in an article that thousands of people were queuing up to receive brain implants from Neurolink, a brain computer interface company owned by Elon Musk.It is reported that Neuralink underwent 155 surgeries on sheep, pigs, and monkeys in 2021, and 294 surgeries last year

On Tuesday local time in the United States, biographer Ashlee Vance revealed in an article that thousands of people were queuing up to receive brain implants from Neurolink, a brain computer interface company owned by Elon Musk.

It is reported that Neuralink underwent 155 surgeries on sheep, pigs, and monkeys in 2021, and 294 surgeries last year. But the company has not yet implanted its device into the human body. Earlier this year, the US Food and Drug Administration (FDA) approved Neuralink for human testing of its device, which Musk described as a "Fitbit on the skull". In September of this year, the company began recruiting volunteers for its first human trial.

Neuralink plans to undergo 11 human surgeries next year, 27 in 2025, and 79 in 2026. Afterwards, the number of surgeries will skyrocket from 499 in 2027 to 22204 in 2030. The company expects annual revenue to reach as high as $100 million within five years.

This article originates from the financial industry


Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])